APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dimethyl Fumarate Delayed-release Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dimethyl Fumarate Delayed-release Capsules Market Analysis and Forecast 2026-2032

27 December 2025197 pages

Choose your research edition.

Industry ResearchDimethyl Fumarate Delayed-release Capsules Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Dimethyl Fumarate Delayed-release Capsules Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Dimethyl Fumarate Delayed-release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dimethyl Fumarate Delayed-release Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dimethyl Fumarate Delayed-release Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Dimethyl Fumarate Delayed-release Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dimethyl Fumarate Delayed-release Capsules include Teva Pharmaceutical, Sichuan Omnis Pharmaceutical, Qilu Pharmaceutical, Mylan, Polpharma, Neuraxpharm, Lupin, Hexal AG and Glenmark Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dimethyl Fumarate Delayed-release Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dimethyl Fumarate Delayed-release Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Dimethyl Fumarate Delayed-release Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dimethyl Fumarate Delayed-release Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dimethyl Fumarate Delayed-release Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dimethyl Fumarate Delayed-release Capsules sales, projected growth trends, production technology, application and end-user industry.

Dimethyl Fumarate Delayed-release Capsules Segment by Company

Teva Pharmaceutical

Sichuan Omnis Pharmaceutical

Qilu Pharmaceutical

Mylan

Polpharma

Neuraxpharm

Lupin

Hexal AG

Glenmark Pharmaceuticals

Cipla

Biogen

Accord Healthcare

Dimethyl Fumarate Delayed-release Capsules Segment by Type

120mg per Unit

240mg per Unit

Dimethyl Fumarate Delayed-release Capsules Segment by Application

Hospital and Clinic

Pharmacy

Other

Dimethyl Fumarate Delayed-release Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dimethyl Fumarate Delayed-release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dimethyl Fumarate Delayed-release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dimethyl Fumarate Delayed-release Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dimethyl Fumarate Delayed-release Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dimethyl Fumarate Delayed-release Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dimethyl Fumarate Delayed-release Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 120mg per Unit Major Manufacturers Table 3. 240mg per Unit Major Manufacturers Table 4. Global Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Other Major Manufacturers Table 8. Dimethyl Fumarate Delayed-release Capsules Industry Trends Table 9. Dimethyl Fumarate Delayed-release Capsules Industry Drivers Table 10. Dimethyl Fumarate Delayed-release Capsules Industry Opportunities and Challenges Table 11. Dimethyl Fumarate Delayed-release Capsules Industry Restraints Table 12. Global Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2021-2026) Table 16. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2027-2032) Table 17. Global Dimethyl Fumarate Delayed-release Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2021-2026) & (K Units) Table 19. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2027-2032) & (K Units) Table 20. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2021-2026) Table 21. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2027-2032) Table 22. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dimethyl Fumarate Delayed-release Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dimethyl Fumarate Delayed-release Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Dimethyl Fumarate Delayed-release Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dimethyl Fumarate Delayed-release Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dimethyl Fumarate Delayed-release Capsules Manufacturers, Product Type & Application Table 30. Global Dimethyl Fumarate Delayed-release Capsules Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dimethyl Fumarate Delayed-release Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2021-2026) Table 37. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2027-2032) Table 38. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2026) & (K Units) Table 40. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2027-2032) & (K Units) Table 41. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2021-2026) Table 42. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2027-2032) Table 43. Global Dimethyl Fumarate Delayed-release Capsules Price by Type (2021-2026) & (US$/Unit) Table 44. Global Dimethyl Fumarate Delayed-release Capsules Price by Type (2027-2032) & (US$/Unit) Table 45. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2021-2026) Table 49. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2027-2032) Table 50. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2027-2032) & (K Units) Table 53. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2021-2026) Table 54. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2027-2032) Table 55. Global Dimethyl Fumarate Delayed-release Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dimethyl Fumarate Delayed-release Capsules Price by Application (2027-2032) & (US$/Unit) Table 57. Teva Pharmaceutical Company Information Table 58. Teva Pharmaceutical Business Overview Table 59. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 61. Teva Pharmaceutical Recent Development Table 62. Sichuan Omnis Pharmaceutical Company Information Table 63. Sichuan Omnis Pharmaceutical Business Overview Table 64. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 66. Sichuan Omnis Pharmaceutical Recent Development Table 67. Qilu Pharmaceutical Company Information Table 68. Qilu Pharmaceutical Business Overview Table 69. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 71. Qilu Pharmaceutical Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 76. Mylan Recent Development Table 77. Polpharma Company Information Table 78. Polpharma Business Overview Table 79. Polpharma Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 81. Polpharma Recent Development Table 82. Neuraxpharm Company Information Table 83. Neuraxpharm Business Overview Table 84. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 86. Neuraxpharm Recent Development Table 87. Lupin Company Information Table 88. Lupin Business Overview Table 89. Lupin Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 91. Lupin Recent Development Table 92. Hexal AG Company Information Table 93. Hexal AG Business Overview Table 94. Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 96. Hexal AG Recent Development Table 97. Glenmark Pharmaceuticals Company Information Table 98. Glenmark Pharmaceuticals Business Overview Table 99. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 101. Glenmark Pharmaceuticals Recent Development Table 102. Cipla Company Information Table 103. Cipla Business Overview Table 104. Cipla Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 106. Cipla Recent Development Table 107. Biogen Company Information Table 108. Biogen Business Overview Table 109. Biogen Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 111. Biogen Recent Development Table 112. Accord Healthcare Company Information Table 113. Accord Healthcare Business Overview Table 114. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 116. Accord Healthcare Recent Development Table 117. North America Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2026) & (K Units) Table 120. North America Dimethyl Fumarate Delayed-release Capsules Sales by Type (2027-2032) & (K Units) Table 121. North America Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 122. North America Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 123. North America Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2026) & (K Units) Table 126. North America Dimethyl Fumarate Delayed-release Capsules Sales by Application (2027-2032) & (K Units) Table 127. North America Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 128. North America Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 129. North America Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 133. North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 134. North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 135. North America Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 136. North America Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 137. United States Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 138. Canada Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 139. Mexico Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 140. Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2026) & (K Units) Table 143. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Type (2027-2032) & (K Units) Table 144. Europe Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Europe Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2026) & (K Units) Table 149. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Application (2027-2032) & (K Units) Table 150. Europe Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Europe Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 156. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 157. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 158. Europe Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Europe Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Germany Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 161. France Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 162. U.K. Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 163. Italy Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 164. Russia Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 165. Spain Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 168. Sweden Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 169. Poland Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 170. China Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 171. China Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 172. China Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2026) & (K Units) Table 173. China Dimethyl Fumarate Delayed-release Capsules Sales by Type (2027-2032) & (K Units) Table 174. China Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 177. China Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 178. China Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2026) & (K Units) Table 179. China Dimethyl Fumarate Delayed-release Capsules Sales by Application (2027-2032) & (K Units) Table 180. China Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2026) & (K Units) Table 185. Asia Dimethyl Fumarate Delayed-release Capsules Sales by Type (2027-2032) & (K Units) Table 186. Asia Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2026) & (K Units) Table 191. Asia Dimethyl Fumarate Delayed-release Capsules Sales by Application (2027-2032) & (K Units) Table 192. Asia Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 199. Asia Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 200. Asia Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 203. South Korea Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 204. India Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 205. Australia Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 229. Argentina Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 230. Chile Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 231. Colombia Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 232. Peru Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 234. Israel Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 235. UAE Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 236. Turkey Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 237. Iran Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 238. Egypt Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Dimethyl Fumarate Delayed-release Capsules Distributors List Table 242. Dimethyl Fumarate Delayed-release Capsules Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Dimethyl Fumarate Delayed-release Capsules Image Figure 2. Global Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dimethyl Fumarate Delayed-release Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 120mg per Unit Image Figure 5. 240mg per Unit Image Figure 6. Global Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dimethyl Fumarate Delayed-release Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Dimethyl Fumarate Delayed-release Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Figure 13. Global Dimethyl Fumarate Delayed-release Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2021-2032) Figure 16. Global Dimethyl Fumarate Delayed-release Capsules Sales (2021-2032) & (K Units) Figure 17. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dimethyl Fumarate Delayed-release Capsules Sales YoY (2021-2032) & (K Units) Figure 20. Europe Dimethyl Fumarate Delayed-release Capsules Sales YoY (2021-2032) & (K Units) Figure 21. China Dimethyl Fumarate Delayed-release Capsules Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Dimethyl Fumarate Delayed-release Capsules Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales YoY (2021-2032) & (K Units) Figure 24. Global Dimethyl Fumarate Delayed-release Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dimethyl Fumarate Delayed-release Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2021-2032) Figure 30. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2021-2032) Figure 33. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2021-2032) Figure 36. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2021-2032) Figure 39. North America Dimethyl Fumarate Delayed-release Capsules Revenue Share by Type (2021-2032) Figure 40. North America Dimethyl Fumarate Delayed-release Capsules Sales Share by Type (2021-2032) Figure 41. North America Dimethyl Fumarate Delayed-release Capsules Revenue Share by Application (2021-2032) Figure 42. North America Dimethyl Fumarate Delayed-release Capsules Sales Share by Application (2021-2032) Figure 43. North America Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country (2021-2032) Figure 44. North America Dimethyl Fumarate Delayed-release Capsules Sales Share by Country (2021-2032) Figure 45. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Share by Type (2021-2032) Figure 46. Europe Dimethyl Fumarate Delayed-release Capsules Sales Share by Type (2021-2032) Figure 47. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Share by Application (2021-2032) Figure 48. Europe Dimethyl Fumarate Delayed-release Capsules Sales Share by Application (2021-2032) Figure 49. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country (2021-2032) Figure 50. Europe Dimethyl Fumarate Delayed-release Capsules Sales Share by Country (2021-2032) Figure 51. China Dimethyl Fumarate Delayed-release Capsules Revenue Share by Type (2021-2032) Figure 52. China Dimethyl Fumarate Delayed-release Capsules Sales Share by Type (2021-2032) Figure 53. China Dimethyl Fumarate Delayed-release Capsules Revenue Share by Application (2021-2032) Figure 54. China Dimethyl Fumarate Delayed-release Capsules Sales Share by Application (2021-2032) Figure 55. Asia Dimethyl Fumarate Delayed-release Capsules Revenue Share by Type (2021-2032) Figure 56. Asia Dimethyl Fumarate Delayed-release Capsules Sales Share by Type (2021-2032) Figure 57. Asia Dimethyl Fumarate Delayed-release Capsules Revenue Share by Application (2021-2032) Figure 58. Asia Dimethyl Fumarate Delayed-release Capsules Sales Share by Application (2021-2032) Figure 59. Asia Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country (2021-2032) Figure 60. Asia Dimethyl Fumarate Delayed-release Capsules Sales Share by Country (2021-2032) Figure 61. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue Share by Type (2021-2032) Figure 62. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Share by Type (2021-2032) Figure 63. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue Share by Application (2021-2032) Figure 64. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Share by Application (2021-2032) Figure 65. SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country (2021-2032) Figure 66. SAMEA Dimethyl Fumarate Delayed-release Capsules Sales Share by Country (2021-2032) Figure 67. Dimethyl Fumarate Delayed-release Capsules Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dimethyl Fumarate Delayed-release Capsules Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg per Unit
  • 240mg per Unit
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva Pharmaceutical
  • Sichuan Omnis Pharmaceutical
  • Qilu Pharmaceutical
  • Mylan
  • Polpharma
  • Neuraxpharm
  • Lupin
  • Hexal AG
  • Glenmark Pharmaceuticals
  • Cipla
  • Biogen
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dimethyl Fumarate Delayed-release Capsules Market by Type
  3. 1.2.1 Global Dimethyl Fumarate Delayed-release Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 120mg per Unit
  5. 1.2.3 240mg per Unit
  6. 1.3 Dimethyl Fumarate Delayed-release Capsules Market by Application
  7. 1.3.1 Global Dimethyl Fumarate Delayed-release Capsules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dimethyl Fumarate Delayed-release Capsules Market Dynamics
  1. 2.1 Dimethyl Fumarate Delayed-release Capsules Industry Trends
  2. 2.2 Dimethyl Fumarate Delayed-release Capsules Industry Drivers
  3. 2.3 Dimethyl Fumarate Delayed-release Capsules Industry Opportunities and Challenges
  4. 2.4 Dimethyl Fumarate Delayed-release Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region
  3. 3.2.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region
  9. 3.4.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Manufacturers
  2. 4.1.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dimethyl Fumarate Delayed-release Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Manufacturers
  6. 4.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dimethyl Fumarate Delayed-release Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dimethyl Fumarate Delayed-release Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dimethyl Fumarate Delayed-release Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dimethyl Fumarate Delayed-release Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Dimethyl Fumarate Delayed-release Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dimethyl Fumarate Delayed-release Capsules Market CR5 and HHI
  16. 4.8.2 2025 Dimethyl Fumarate Delayed-release Capsules Tier 1, Tier 2, and Tier 3
5 Dimethyl Fumarate Delayed-release Capsules Market by Type
  1. 5.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type
  2. 5.1.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type
  6. 5.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dimethyl Fumarate Delayed-release Capsules Price by Type
6 Dimethyl Fumarate Delayed-release Capsules Market by Application
  1. 6.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application
  2. 6.1.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application
  6. 6.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dimethyl Fumarate Delayed-release Capsules Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Sichuan Omnis Pharmaceutical
  8. 7.2.1 Sichuan Omnis Pharmaceutical Company Information
  9. 7.2.2 Sichuan Omnis Pharmaceutical Business Overview
  10. 7.2.3 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  12. 7.2.5 Sichuan Omnis Pharmaceutical Recent Developments
  13. 7.3 Qilu Pharmaceutical
  14. 7.3.1 Qilu Pharmaceutical Company Information
  15. 7.3.2 Qilu Pharmaceutical Business Overview
  16. 7.3.3 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  18. 7.3.5 Qilu Pharmaceutical Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Polpharma
  26. 7.5.1 Polpharma Company Information
  27. 7.5.2 Polpharma Business Overview
  28. 7.5.3 Polpharma Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  30. 7.5.5 Polpharma Recent Developments
  31. 7.6 Neuraxpharm
  32. 7.6.1 Neuraxpharm Company Information
  33. 7.6.2 Neuraxpharm Business Overview
  34. 7.6.3 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  36. 7.6.5 Neuraxpharm Recent Developments
  37. 7.7 Lupin
  38. 7.7.1 Lupin Company Information
  39. 7.7.2 Lupin Business Overview
  40. 7.7.3 Lupin Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  42. 7.7.5 Lupin Recent Developments
  43. 7.8 Hexal AG
  44. 7.8.1 Hexal AG Company Information
  45. 7.8.2 Hexal AG Business Overview
  46. 7.8.3 Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  48. 7.8.5 Hexal AG Recent Developments
  49. 7.9 Glenmark Pharmaceuticals
  50. 7.9.1 Glenmark Pharmaceuticals Company Information
  51. 7.9.2 Glenmark Pharmaceuticals Business Overview
  52. 7.9.3 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  54. 7.9.5 Glenmark Pharmaceuticals Recent Developments
  55. 7.10 Cipla
  56. 7.10.1 Cipla Company Information
  57. 7.10.2 Cipla Business Overview
  58. 7.10.3 Cipla Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  60. 7.10.5 Cipla Recent Developments
  61. 7.11 Biogen
  62. 7.11.1 Biogen Company Information
  63. 7.11.2 Biogen Business Overview
  64. 7.11.3 Biogen Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  66. 7.11.5 Biogen Recent Developments
  67. 7.12 Accord Healthcare
  68. 7.12.1 Accord Healthcare Company Information
  69. 7.12.2 Accord Healthcare Business Overview
  70. 7.12.3 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  72. 7.12.5 Accord Healthcare Recent Developments
8 North America
  1. 8.1 North America Dimethyl Fumarate Delayed-release Capsules Market Size by Type
  2. 8.1.1 North America Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Dimethyl Fumarate Delayed-release Capsules Price by Type (2021-2032)
  5. 8.2 North America Dimethyl Fumarate Delayed-release Capsules Market Size by Application
  6. 8.2.1 North America Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Dimethyl Fumarate Delayed-release Capsules Price by Application (2021-2032)
  9. 8.3 North America Dimethyl Fumarate Delayed-release Capsules Market Size by Country
  10. 8.3.1 North America Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dimethyl Fumarate Delayed-release Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dimethyl Fumarate Delayed-release Capsules Market Size by Type
  2. 9.1.1 Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Dimethyl Fumarate Delayed-release Capsules Price by Type (2021-2032)
  5. 9.2 Europe Dimethyl Fumarate Delayed-release Capsules Market Size by Application
  6. 9.2.1 Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Dimethyl Fumarate Delayed-release Capsules Price by Application (2021-2032)
  9. 9.3 Europe Dimethyl Fumarate Delayed-release Capsules Market Size by Country
  10. 9.3.1 Europe Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dimethyl Fumarate Delayed-release Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dimethyl Fumarate Delayed-release Capsules Market Size by Type
  2. 10.1.1 China Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Dimethyl Fumarate Delayed-release Capsules Price by Type (2021-2032)
  5. 10.2 China Dimethyl Fumarate Delayed-release Capsules Market Size by Application
  6. 10.2.1 China Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Dimethyl Fumarate Delayed-release Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dimethyl Fumarate Delayed-release Capsules Market Size by Type
  2. 11.1.1 Asia Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Dimethyl Fumarate Delayed-release Capsules Price by Type (2021-2032)
  5. 11.2 Asia Dimethyl Fumarate Delayed-release Capsules Market Size by Application
  6. 11.2.1 Asia Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Dimethyl Fumarate Delayed-release Capsules Price by Application (2021-2032)
  9. 11.3 Asia Dimethyl Fumarate Delayed-release Capsules Market Size by Country
  10. 11.3.1 Asia Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dimethyl Fumarate Delayed-release Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dimethyl Fumarate Delayed-release Capsules Market Size by Type
  2. 12.1.1 SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dimethyl Fumarate Delayed-release Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Dimethyl Fumarate Delayed-release Capsules Market Size by Application
  6. 12.2.1 SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dimethyl Fumarate Delayed-release Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Dimethyl Fumarate Delayed-release Capsules Market Size by Country
  10. 12.3.1 SAMEA Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dimethyl Fumarate Delayed-release Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dimethyl Fumarate Delayed-release Capsules Value Chain Analysis
  2. 13.1.1 Dimethyl Fumarate Delayed-release Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dimethyl Fumarate Delayed-release Capsules Production Mode & Process
  6. 13.2 Dimethyl Fumarate Delayed-release Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dimethyl Fumarate Delayed-release Capsules Distributors
  9. 13.2.3 Dimethyl Fumarate Delayed-release Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst